Cardiovascular risk reduction in chronic myeloid leukemia patients treated with the tyrosine kinase inhibitors
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2020-10-01
|
| Series: | Hematology, Transfusion and Cell Therapy |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2531137920301668 |
| _version_ | 1818211725708623872 |
|---|---|
| author | N. Lopina I. Dmytrenko D. Lopin D. Hamov I. Dyagil |
| author_facet | N. Lopina I. Dmytrenko D. Lopin D. Hamov I. Dyagil |
| author_sort | N. Lopina |
| collection | DOAJ |
| first_indexed | 2024-12-12T05:37:04Z |
| format | Article |
| id | doaj.art-e2c2fdbe8ff64cafaa36133fea2dd05b |
| institution | Directory Open Access Journal |
| issn | 2531-1379 |
| language | English |
| last_indexed | 2024-12-12T05:37:04Z |
| publishDate | 2020-10-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Hematology, Transfusion and Cell Therapy |
| spelling | doaj.art-e2c2fdbe8ff64cafaa36133fea2dd05b2022-12-22T00:36:07ZengElsevierHematology, Transfusion and Cell Therapy2531-13792020-10-01421819Cardiovascular risk reduction in chronic myeloid leukemia patients treated with the tyrosine kinase inhibitorsN. Lopina0I. Dmytrenko1D. Lopin2D. Hamov3I. Dyagil4LLC “MED INFORM GROUP”, Kharkiv, Ukraine; Corresponding author.National Scientific Center of Radiation Medicine of the National Academy of Medical Sciences of Ukraine, Department of Radiation Oncohematology and Stem Cell Transplantation, Kyiv, UkraineSI “V. T. Zaitsev Institite of General and Urgent Surgery of NAMS of Ukraine”, Kyiv, Ukraine“Cherkasy Regional Oncology Dispensary” of Cherkasy Regional Council, Regional Medical Hematology Center, Cherkasy, UkraineNational Scientific Center of Radiation Medicine of the National Academy of Medical Sciences of Ukraine, Department of Radiation Oncohematology and Stem Cell Transplantation, Kyiv, Ukrainehttp://www.sciencedirect.com/science/article/pii/S2531137920301668 |
| spellingShingle | N. Lopina I. Dmytrenko D. Lopin D. Hamov I. Dyagil Cardiovascular risk reduction in chronic myeloid leukemia patients treated with the tyrosine kinase inhibitors Hematology, Transfusion and Cell Therapy |
| title | Cardiovascular risk reduction in chronic myeloid leukemia patients treated with the tyrosine kinase inhibitors |
| title_full | Cardiovascular risk reduction in chronic myeloid leukemia patients treated with the tyrosine kinase inhibitors |
| title_fullStr | Cardiovascular risk reduction in chronic myeloid leukemia patients treated with the tyrosine kinase inhibitors |
| title_full_unstemmed | Cardiovascular risk reduction in chronic myeloid leukemia patients treated with the tyrosine kinase inhibitors |
| title_short | Cardiovascular risk reduction in chronic myeloid leukemia patients treated with the tyrosine kinase inhibitors |
| title_sort | cardiovascular risk reduction in chronic myeloid leukemia patients treated with the tyrosine kinase inhibitors |
| url | http://www.sciencedirect.com/science/article/pii/S2531137920301668 |
| work_keys_str_mv | AT nlopina cardiovascularriskreductioninchronicmyeloidleukemiapatientstreatedwiththetyrosinekinaseinhibitors AT idmytrenko cardiovascularriskreductioninchronicmyeloidleukemiapatientstreatedwiththetyrosinekinaseinhibitors AT dlopin cardiovascularriskreductioninchronicmyeloidleukemiapatientstreatedwiththetyrosinekinaseinhibitors AT dhamov cardiovascularriskreductioninchronicmyeloidleukemiapatientstreatedwiththetyrosinekinaseinhibitors AT idyagil cardiovascularriskreductioninchronicmyeloidleukemiapatientstreatedwiththetyrosinekinaseinhibitors |